RESUMEN
INTRODUCTION: Despite the availability of effective iron chelators, transfusion-related morbidity is still a challenge in chronically transfused patients with myelodysplastic syndromes (MDS). In these patients, transfusion-induced iron overload may lead to organ dysfunction or even organ failure. In addition, iron overload is associated with reduced overall survival in MDS. Areas covered: During the past 10 years, various guidelines for the management of MDS patients with iron overload have been proposed. In the present article, we provide our updated recommendations for the diagnosis, prevention and therapy of iron overload in MDS. In addition, we propose refined treatment response criteria. As in 2006 and 2007, recommendations were discussed and formulated by participants of our Austrian MDS platform in a series of meetings in 2016 and 2017. Expert commentary: Our updated recommendations should support early recognition of iron overload, optimal patient management and the measurement of clinical responses to chelation treatment in daily practice.
Asunto(s)
Transfusión Sanguínea , Sobrecarga de Hierro , Síndromes Mielodisplásicos , Reacción a la Transfusión , Humanos , Sobrecarga de Hierro/sangre , Sobrecarga de Hierro/prevención & control , Síndromes Mielodisplásicos/sangre , Síndromes Mielodisplásicos/terapia , Guías de Práctica Clínica como Asunto , Reacción a la Transfusión/sangre , Reacción a la Transfusión/prevención & controlRESUMEN
T-cell prolymphocytic leukemia (T-PLL) is a rare and aggressive T-lymphoid malignancy usually refractory to current treatment strategies and associated with short overall survival. By applying next-generation functional testing of primary patient-derived lymphoma cells using a library of 106 US Food and Drug Administration (FDA)-approved anticancer drugs or compounds currently in clinical development, we set out to identify novel effective treatments for T-PLL patients. We found that the B-cell lymphoma 2 (BCL-2) inhibitor venetoclax (ABT-199) demonstrated the strongest T-PLL-specific response when comparing individual ex vivo drug response in 86 patients with refractory hematologic malignancies. Mechanistically, responses to venetoclax correlated with protein expression of BCL-2 but not with expression of the BCL-2 family members myeloid cell leukemia 1 (MCL-1) and BCL-XL in lymphoma cells. BCL-2 expression was inversely correlated with the expression of MCL-1. Based on the ex vivo responses, venetoclax treatment was commenced in 2 late-stage refractory T-PLL patients resulting in clinical responses. Our findings demonstrate first evidence of single-agent activity of venetoclax both ex vivo and in humans, offering a novel agent in T-PLL.
Asunto(s)
Antineoplásicos/uso terapéutico , Compuestos Bicíclicos Heterocíclicos con Puentes/uso terapéutico , Leucemia Prolinfocítica de Células T/tratamiento farmacológico , Terapia Molecular Dirigida , Proteínas Proto-Oncogénicas c-bcl-2/antagonistas & inhibidores , Sulfonamidas/uso terapéutico , Adulto , Antineoplásicos/farmacología , Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Compuestos Bicíclicos Heterocíclicos con Puentes/farmacología , Línea Celular Tumoral , Relación Dosis-Respuesta a Droga , Evaluación Preclínica de Medicamentos/métodos , Resistencia a Antineoplásicos , Femenino , Ensayos Analíticos de Alto Rendimiento , Humanos , Leucemia Prolinfocítica de Células T/diagnóstico , Leucemia Prolinfocítica de Células T/metabolismo , Masculino , Persona de Mediana Edad , Recurrencia , Sulfonamidas/farmacología , Resultado del TratamientoRESUMEN
The major turnip (Brassica rapa) pollen allergen, belongs to a family of calcium-binding proteins (i.e., two EF-hand proteins), which occur as highly cross-reactive allergens in pollen of weeds, grasses and trees. In this study, the IgE binding capacity and allergenic activity of three recombinant allergen variants containing mutations in their calcium-binding sites were analyzed in sensitized patients with the aim to identify the most suitable hypoallergenic molecule for specific immunotherapy. Analysis of the wildtype allergen and the mutants regarding IgE reactivity and activation of basophils in allergic patients indicated that the allergen derivative mutated in both calcium-binding domains had the lowest allergenic activity. Gel filtration and circular dichroism experiments showed that both, the wildtype and the double mutant, occurred as dimers in solution and assumed alpha-helical fold, respectively. However, both fold and thermal stability were considerably reduced in the double mutant. The use of bioinformatic tools for evaluation of the solvent accessibility and charge distribution suggested that the reduced IgE reactivity and different structural properties of the double mutant may be due to a loss of negatively charged amino acids on the surface. Interestingly, immunization of rabbits showed that only the double mutant but not the wildtype allergen induced IgG antibodies which recognized the allergen and blocked binding of allergic patients IgE. Due to the extensive structural similarity and cross-reactivity between calcium-binding pollen allergens the hypoallergenic double mutant may be useful not only for immunotherapy of turnip pollen allergy, but also for the treatment of allergies to other two EF-hand pollen allergens.
Asunto(s)
Basófilos/efectos de los fármacos , Brassica rapa/inmunología , Proteínas de Unión al Calcio/inmunología , Proteínas de Unión al Calcio/uso terapéutico , Desensibilización Inmunológica/métodos , Proteínas de Plantas/inmunología , Proteínas de Plantas/uso terapéutico , Rinitis Alérgica Estacional/terapia , Adulto , Alérgenos/genética , Alérgenos/inmunología , Alérgenos/uso terapéutico , Secuencia de Aminoácidos , Animales , Formación de Anticuerpos/efectos de los fármacos , Antígenos de Plantas/genética , Antígenos de Plantas/uso terapéutico , Basófilos/inmunología , Proteínas de Unión al Calcio/genética , Degranulación de la Célula/efectos de los fármacos , Células Cultivadas , Reacciones Cruzadas , Femenino , Humanos , Inmunoglobulina E/metabolismo , Masculino , Datos de Secuencia Molecular , Mutación/genética , Proteínas de Plantas/genética , Polen/efectos adversos , Polen/inmunología , Conformación Proteica , Ingeniería de Proteínas , Conejos , Rinitis Alérgica Estacional/inmunología , Adulto JovenRESUMEN
Rearrangements of chromosome band 3q26.2 lead to overexpression of the EVI1 gene and are associated with a poor prognosis in myeloid malignancies. EVI1 is also overexpressed in some cases without 3q26 rearrangements. To uncover its prognostic significance in this patient group, however, it may be necessary to distinguish among several known 5'-end variants of its mRNA. According to a recent report, overexpression of the transcript variant EVI1_1d was associated with shortened survival in acute myeloid leukemia (AML), but overexpression of MDS1/EVI1, whose protein product differs structurally and functionally from that of all other known EVI1 5'-end variants, was not. The aim of the present study was to determine, for the first time, the expression and prognostic significance of all known EVI1 5'-end variants in AML. Quantitative RT-PCR was used to measure the expression of EVI1_1a, EVI1_1b, EVI1_1d, EVI1_3L, and MDS1/EVI1 in 266 samples from patients with de novo AML. To correlate expression of the EVI1 5'-end variants with survival parameters, regression analyses were performed. 41/266 patients (15.4%) overexpressed at least one, but more often several or all, EVI1 transcript type(s). High expression of each of the EVI1 mRNA variants, including MDS1/EVI1, was significantly associated with shortened continuous complete remission in the total patient population as well as in the subgroups of patients with intermediate risk or normal cytogenetics. The present study therefore shows that high levels of each of the known EVI1 mRNA 5'-end variants represents an adverse prognostic factor in de novo AML without 3q26 rearrangements. This article contains Supplementary Material available at http://www.interscience.wiley.com/jpages/1045-2257/suppmat.
Asunto(s)
Regiones no Traducidas 5'/genética , Proteínas de Unión al ADN/genética , Regulación Leucémica de la Expresión Génica/fisiología , Leucemia Mieloide Aguda/genética , Proteínas de Fusión Oncogénica/genética , Proto-Oncogenes/genética , ARN Mensajero/genética , Factores de Transcripción/genética , Regiones no Traducidas 5'/metabolismo , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Estudios de Casos y Controles , Cromosomas Humanos Par 3/genética , Proteínas de Unión al ADN/metabolismo , Femenino , Reordenamiento Génico , Humanos , Leucemia Mieloide Aguda/metabolismo , Leucemia Mieloide Aguda/mortalidad , Proteína del Locus del Complejo MDS1 y EV11 , Masculino , Persona de Mediana Edad , Proteínas de Fusión Oncogénica/metabolismo , Reacción en Cadena de la Polimerasa , Pronóstico , ARN Mensajero/metabolismo , Inducción de Remisión , Estudios Retrospectivos , Tasa de Supervivencia , Factores de Transcripción/metabolismo , Resultado del TratamientoRESUMEN
On the basis of IgE epitope mapping data, we have produced three allergen fragments comprising aa 1-33, 1-57, and 31-110 of the major timothy grass pollen allergen Phl p 6 aa 1-110 by expression in Escherichia coli and chemical synthesis. Circular dichroism analysis showed that the purified fragments lack the typical alpha-helical fold of the complete allergen. Superposition of the sequences of the fragments onto the three-dimensional allergen structure indicated that the removal of only one of the four helices had led to the destabilization of the alpha helical structure of Phl p 6. The lack of structural fold was accompanied by a strong reduction of IgE reactivity and allergenic activity of the three fragments as determined by basophil histamine release in allergic patients. Each of the three Phl p 6 fragments adsorbed to CFA induced Phl p 6-specific IgG Abs in rabbits. However, immunization of mice with fragments adsorbed to an adjuvant allowed for human use (AluGel-S) showed that only the Phl p 6 aa 31-110 induced Phl p 6-specific IgG Abs. Anti-Phl p 6 IgG Abs induced by vaccination with Phl p 6 aa 31-110 inhibited patients' IgE reactivity to the wild-type allergen as well as Phl p 6-induced basophil degranulation. Our results are of importance for the design of hypoallergenic allergy vaccines. They show that it has to be demonstrated that the hypoallergenic derivative induces a robust IgG response in a formulation that can be used in allergic patients.
Asunto(s)
Alérgenos/biosíntesis , Alérgenos/genética , Regulación hacia Abajo/inmunología , Proteínas de Plantas/síntesis química , Proteínas de Plantas/genética , Proteínas Recombinantes de Fusión/síntesis química , Proteínas Recombinantes de Fusión/genética , Vacunas/genética , Alérgenos/administración & dosificación , Alérgenos/inmunología , Animales , Regulación hacia Abajo/genética , Femenino , Regulación de la Expresión Génica/inmunología , Humanos , Sueros Inmunes/biosíntesis , Inmunoglobulina E/metabolismo , Inmunoglobulina G/biosíntesis , Inmunoglobulina G/metabolismo , Ratones , Ratones Endogámicos BALB C , Fragmentos de Péptidos/administración & dosificación , Fragmentos de Péptidos/síntesis química , Fragmentos de Péptidos/genética , Fragmentos de Péptidos/inmunología , Phleum/genética , Phleum/inmunología , Proteínas de Plantas/administración & dosificación , Proteínas de Plantas/inmunología , Polen/genética , Polen/inmunología , Ingeniería de Proteínas/métodos , Pliegue de Proteína , Estructura Secundaria de Proteína , Conejos , Proteínas Recombinantes de Fusión/administración & dosificación , Proteínas Recombinantes de Fusión/inmunología , Vacunas/administración & dosificación , Vacunas/síntesis química , Vacunas/inmunologíaRESUMEN
Grass pollen belong to the most important allergen sources involved in the elicitation of allergic asthma. We have isolated cDNAs coding for Bermuda grass (Cynodon dactylon) and timothy grass (Phleum pratense) pollen allergens, belonging to a family of pectin-degrading enzymes (i.e., polygalacturonases). The corresponding allergens, termed Cyn d 13 and Phl p 13, represent glycoproteins of approximately 42 kDa and isoelectric points of 7.5. rPhl p 13 was expressed in Escherichia coli and purified to homogeneity. Immunogold electron microscopy using rabbit anti-rPhl p 13 Abs demonstrated that in dry pollen group 13, allergens represent primarily intracellular proteins, whereas exposure of pollen to rainwater caused a massive release of cytoplasmic material containing submicronic particles of respirable size, which were coated with group 13 allergens. The latter may explain respiratory sensitization to group 13 allergens and represents a possible pathomechanism in the induction of asthma attacks after heavy rainfalls. rPhl p 13 was recognized by 36% of grass pollen allergic patients, showed IgE binding capacity comparable to natural Phl p 13, and induced specific and dose-dependent basophil histamine release. Epitope mapping studies localized major IgE epitopes to the C terminus of the molecule outside the highly conserved functional polygalacturonase domains. The latter result explains why rPhl p 13 contains grass pollen-specific IgE epitopes and may be used to diagnose genuine sensitization to grass pollen. Our finding that rabbit anti-rPhl p 13 Abs blocked patients' IgE binding to the allergen suggests that rPhl p 13 may be used for immunotherapy of sensitized patients.
Asunto(s)
Alérgenos/inmunología , Artemisia/inmunología , Phleum/inmunología , Polen/enzimología , Polen/inmunología , Poligalacturonasa/inmunología , Hipersensibilidad Respiratoria/enzimología , Hipersensibilidad Respiratoria/inmunología , Alérgenos/biosíntesis , Alérgenos/química , Alérgenos/aislamiento & purificación , Alérgenos/ultraestructura , Secuencia de Aminoácidos , Anticuerpos Bloqueadores/biosíntesis , Anticuerpos Bloqueadores/metabolismo , Artemisia/enzimología , Artemisia/ultraestructura , Basófilos/inmunología , Basófilos/metabolismo , Unión Competitiva/inmunología , Biomarcadores/análisis , Secuencia Conservada , Desensibilización Inmunológica/métodos , Liberación de Histamina/inmunología , Inmunoglobulina E/metabolismo , Inmunoglobulina G/biosíntesis , Inmunoglobulina G/metabolismo , Microscopía Inmunoelectrónica , Datos de Secuencia Molecular , Tamaño de la Partícula , Pectinas/metabolismo , Phleum/enzimología , Phleum/ultraestructura , Proteínas de Plantas/biosíntesis , Proteínas de Plantas/química , Proteínas de Plantas/aislamiento & purificación , Polen/ultraestructura , Poligalacturonasa/química , Poligalacturonasa/ultraestructura , Unión Proteica/inmunología , Estructura Terciaria de Proteína , Hipersensibilidad Respiratoria/diagnóstico , Análisis de Secuencia de ProteínaRESUMEN
The grass pollen allergen, Phl p 7, belongs to a family of highly cross-reactive calcium-binding pollen allergens. Because Phl p 7 contains most of the disease-eliciting epitopes of pollen-derived calcium-binding allergens, hypoallergenic variants were engineered according to the x-ray crystal structure of Phl p 7 for allergy vaccination. In three recombinant variants, amino acids essential for calcium binding were mutated, and two peptides comprising the N- and C-terminal half were obtained by synthetic peptide chemistry. As determined by circular dichroism analysis and size exclusion chromatography coupled to mass spectrometry, recombinant mutants showed altered structural fold and lacked calcium-binding capacity, whereas the two synthetic peptides had completely lost their structural fold. Allergic patients' IgE Ab binding was strongest reduced to the variant containing two mutations in each of the two calcium-binding sites and to the peptides. Basophil histamine release and skin test experiments in allergic patients identified the peptides as the vaccine candidates with lowest allergenic activity. Immunization of rabbits with the peptides induced IgG Abs that blocked allergic patients' IgE binding to Phl p 7 and inhibited allergen-induced basophil degranulation. Our results indicate that disruption of an allergen's three-dimensional structure represents a general strategy for the generation of hypoallergenic allergy vaccines, and demonstrate the importance of allergen-specific IgG Abs for the inhibition of immediate allergic symptoms.
Asunto(s)
Alérgenos/genética , Proteínas de Unión al Calcio/genética , Desensibilización Inmunológica/métodos , Phleum/inmunología , Proteínas de Plantas/genética , Vacunas/síntesis química , Vacunas/genética , Alérgenos/química , Alérgenos/inmunología , Alérgenos/metabolismo , Animales , Antialérgicos/administración & dosificación , Antialérgicos/síntesis química , Antialérgicos/inmunología , Antígenos de Plantas , Basófilos/inmunología , Basófilos/metabolismo , Sitios de Unión de Anticuerpos/genética , Unión Competitiva/inmunología , Proteínas de Unión al Calcio/química , Proteínas de Unión al Calcio/inmunología , Proteínas de Unión al Calcio/metabolismo , Degranulación de la Célula , Línea Celular Tumoral , Reacciones Cruzadas , Relación Dosis-Respuesta Inmunológica , Liberación de Histamina/inmunología , Humanos , Inmunoglobulina E/metabolismo , Inmunoglobulina G/biosíntesis , Inmunoglobulina G/metabolismo , Ratones , Mutagénesis Sitio-Dirigida , Fragmentos de Péptidos/administración & dosificación , Fragmentos de Péptidos/genética , Fragmentos de Péptidos/inmunología , Fragmentos de Péptidos/metabolismo , Phleum/química , Phleum/genética , Proteínas de Plantas/química , Proteínas de Plantas/inmunología , Proteínas de Plantas/metabolismo , Polen/genética , Polen/inmunología , Conejos , Ratas , Pruebas Cutáneas , Relación Estructura-Actividad , Vacunas/administración & dosificación , Vacunas/inmunologíaRESUMEN
Almost 500 million people worldwide suffer from Type I allergy, a genetically determined immunodisorder which is based on the production of IgE antibodies against per se harmless antigens (allergens). Due to their worldwide distribution and heavy pollen production, grasses represent a major allergen source for approximately 40% of allergic patients. We purified Phl p 4, a major timothy grass (Phleum pratense) pollen allergen with a molecular mass of 61.3 kDa and a pl of 9.6 to homogeneity. Circular dichroism spectroscopical analysis indicates that Phl p 4 contains a mixed alpha-helical/beta-pleated secondary structure and, unlike many other allergens, showed no reversible unfolding after thermal denaturation. We show that Phl p 4 is a major allergen which reacts with IgE antibodies of 75% of grass pollen allergic patients (n=150) and induces basophil histamine release as well as immediate type skin reactions in sensitized individuals. Phl p 4-specific IgE from three patients as well as two rabbit-anti Phl p 4 antisera cross-reacted with allergens present in pollen of trees, grasses, weeds as well as plant-derived food. Rabbit antibodies raised against Phl p 4 also inhibited the binding of allergic patients IgE to Phl p 4. Phl p 4 may thus be used for diagnosis and treatment of sensitized allergic patients.
Asunto(s)
Alérgenos/aislamiento & purificación , Phleum/inmunología , Proteínas de Plantas/aislamiento & purificación , Polen/inmunología , Alérgenos/química , Alérgenos/inmunología , Animales , Western Blotting , Dicroismo Circular , Reacciones Cruzadas/inmunología , Electroforesis en Gel de Poliacrilamida , Liberación de Histamina , Humanos , Inmunoglobulina E/inmunología , Focalización Isoeléctrica , Peso Molecular , Ácido Peryódico/farmacología , Phleum/química , Proteínas de Plantas/química , Proteínas de Plantas/inmunología , Polen/química , Conformación Proteica , Pliegue de Proteína , Conejos , Pruebas CutáneasRESUMEN
More than 100 million individuals exhibit IgE-mediated allergic reactions against Phl p 2, a major allergen from timothy grass pollen. We isolated cDNA coding for three Phl p 2-specific human IgE antibodies from a combinatorial library, which was constructed from lymphocytes of a grass pollen-allergic patient. Recombinant Phl p 2-specific IgE antibody fragments (Fab) recognized a fragment comprising the 64 N-terminal amino acids of Phl p 2 and cross-reacted with group 2 allergens from seven grass species. cDNA coding for the variable regions of one of the IgE Fab were cloned into aplasmid vector expressing the constant region of human IgG(1) to obtain a complete, recombinant Phl p 2-specific human IgG(1). This antibody blocked the binding of grass pollen-allergic patients IgE (n=26; mean inhibition: 58%) to Phl p 2 and caused a 100-fold reduction of Phl p 2-induced basophil histamine release. The recombinant human Phl p 2-specific IgG(1) may be used for environmental allergen detection, for standardization of diagnostic as well as therapeutic grass pollen allergen preparations and for passive therapy of grass pollen allergy.